| Authors: |
Rohrberg KS; Department of Oncology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark., Lopez JS; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, United Kingdom., Milhem MM; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa., Blank CU; Division of Molecular Oncology and Immunology, Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.; Department of Hematology and Oncology, University Clinic Regensburg (UKR), Regensburg, Germany., Reijers I; Division of Molecular Oncology and Immunology, Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands., Thistlethwaite F; The Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Plummer R; Newcastle University, Newcastle upon Tyne, United Kingdom., Piha-Paul SA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Shum E; Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York., Shaw HM; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Clinical Research Facility, National Health Service (NHS) Foundation Trust, London, United Kingdom.; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, United Kingdom., Debruyne PR; Department of Medical Oncology, Kortrijk Cancer Centre, AZ Groeninge, Kortrijk, Belgium.; Medical Technology Research Centre (MTRC), School of Allied Health and Social Care, Faculty of Health, Medicine and Social Care, Anglia Ruskin University, Chelmsford, United Kingdom.; School of Nursing and Midwifery, Faculty of Health, University of Plymouth, Plymouth, United Kingdom., Lao C; Division of Hematology Oncology, Department of Internal Medicine, Rogel Cancer Center, Ann Arbor, Michigan., Baurain JF; Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UC Louvain and Institute for Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium., Choe JH; Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Gort E; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands., Zhao Y; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida., Jerusalem G; Medical Oncology Department, CHU Liège and Liège University, Liege, Belgium., Schöffski P; General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Chen AW; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiology, Columbia University, New York, New York., Cohen EA; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiology, Columbia University, New York, New York., Mankowski WC; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiology, Columbia University, New York, New York., Roshkovan L; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Katz SI; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Kontos D; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiology, Columbia University, New York, New York., Brady LK; Genmab US., Plainsboro, New Jersey., Qutaish M; Genmab US., Plainsboro, New Jersey., Castro PG; Genmab B.V., Utrecht, the Netherlands., Pencheva N; Genmab B.V., Utrecht, the Netherlands., Bajaj G; Genmab US., Plainsboro, New Jersey., Fu Y; Genmab US., Plainsboro, New Jersey., Windfeld K; Genmab A/S, Copenhagen, Denmark., Reiter P; Genmab A/S, Copenhagen, Denmark., Jure-Kunkel M; Genmab US., Plainsboro, New Jersey., Higgs BW; Genmab US., Plainsboro, New Jersey., Amiri KI; Genmab US., Plainsboro, New Jersey., Ahmadi T; Genmab US., Plainsboro, New Jersey., Forssmann U; Genmab A/S, Copenhagen, Denmark., Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory, Emory University School of Medicine, Atlanta, Georgia., Vergote I; Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium. |
